This inventor holds 1 USPTO granted patent and 9 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Guobin Miao: Innovator in Heterocyclic PAD4 Inhibitors
Introduction
Guobin Miao is a prominent inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of heterocyclic compounds.
Latest Patents
Miao holds a patent for "Heterocyclic PAD4 inhibitors," which relates to substituted heterocyclic compounds of Formula (Ia). These compounds serve as inhibitors of the PAD4 enzyme, and the patent outlines methods for preparing these compounds, pharmaceutical compositions that include them, and their use in treating diseases associated with PAD4 enzyme activity. He has 1 patent to his name.
Career Highlights
Guobin Miao is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, contributing to the development of new therapeutic options.
Collaborations
Miao collaborates with various professionals in his field, including his coworker Kumaravel Selvakumar. Their combined expertise enhances the research and development processes at Bristol-Myers Squibb.
Conclusion
Guobin Miao is a dedicated inventor whose work on heterocyclic PAD4 inhibitors showcases his commitment to advancing medical science. His contributions are vital in the ongoing quest for effective treatments for diseases linked to PAD4 enzyme activity.